Curanex Pharmaceuticals Inc Common Stock

CURXNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
5.07 USD
↗ 0.11 (2.12%)🟢LIVE (AS OF 11:40 AM EDT)
🟢Market: OPEN

Curanex Pharmaceuticals Inc Common Stock (CURX) is currently trading at $5.07. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest CURX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 5, 2026.

Open?$5.09
High?$5.68
Low?$4.88
Prev. Close?$4.96
Volume?38.3K
Avg. Volume?24.3K
VWAP?$5.07
Rel. Volume?1.58x
Bid / Ask
Bid?$4.15 × 100
Ask?$5.83 × 100
Spread?$1.68
Midpoint?$4.99
Valuation & Ratios
Market Cap?7.8M
Shares Out?1.6M
Float?9.1M
Float %?32.2%
P/E Ratio?N/A
P/B Ratio?1.62
EPS?-$6.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicBiotech - Drug Development›Immunology & Autoimmune
Employees
6
Market Cap
7.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.curanexpharma.com
Listed
2025-08-26
Address
2 JERICHO PLAZA,
JERICHO, NY 11753
Phone: 718-673-6078
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?7.43Safe
Confidence?23%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.03%Low
Short Interest?2.8K
Days to Cover?1.0
Free Float9.1M
Avg Daily Volume31.6K
Settlement Date2026-09-15
Financial Health
Current Ratio?45.95Strong
Quick Ratio?45.95Strong
Cash Ratio?28.17Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
84
1.62CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-218.7%WEAK▾
ROA?
S&P
3
-206.3%WEAK▾
Cash Flow & Enterprise
FCF?$-12079094
Enterprise Value?$4.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist